Elevance Health Inc. (NYSE:ELV)

The valuation ratios for Elevance Health Inc. exhibit a consistent cyclical pattern between March 2022 and September 2026, characterized by a prolonged contraction in valuation multiples followed by a distinct recovery phase starting in early 2026.

Price to Earnings (P/E) and Price to Operating Profit (P/OP)

Earnings-based multiples followed a nearly identical trajectory throughout the period. The P/E ratio began at 20.46 and remained relatively stable, fluctuating between 17.03 and 19.80 through December 2023. A significant contraction occurred between March 2024 and June 2025, with the P/E ratio reaching a period low of 12.71. Similarly, the P/OP ratio declined from an initial 17.53 to a low of 9.63 in June 2025. By September 2026, both ratios rebounded sharply, with P/E rising to 18.25 and P/OP reaching 19.01, indicating a restoration of valuation premiums.

Price to Sales (P/S)

The P/S ratio demonstrates a sustained downward trend for the majority of the analyzed timeline. From a peak of 0.89 in March 2022, the ratio declined steadily, reaching a trough of 0.36 by June 2025. This represents a substantial compression in the market value assigned to each dollar of revenue. While a recovery is noted in the final three quarters, ending at 0.47 in September 2026, the ratio remains significantly lower than the levels observed in 2022.

Price to Book Value (P/BV)

The P/BV ratio mirrors the broader valuation trend, starting at 3.55 in March 2022. After maintaining a range between 2.86 and 3.02 for several quarters, the ratio experienced a sharp decline starting in September 2024, bottoming out at 1.56 in June 2025. A subsequent recovery trend is evident through September 2026, where the ratio increased to 2.10.

The synchronous decline across all four valuation metrics through June 2025 suggests a period of systemic valuation compression. The subsequent upward movement throughout 2026 indicates a positive shift in market sentiment or a fundamental re-rating of the company's equity value relative to its financial performance.

The valuation metrics for the period between March 31, 2022, and September 30, 2026, exhibit a cyclical pattern characterized by an initial period of stability, a significant contraction in the price-to-earnings (P/E) ratio, and a subsequent recovery phase.

P/E Ratio Trend Analysis

The P/E ratio began at 20.46 in March 2022 and remained relatively stable, fluctuating between 17.03 and 19.80 through the end of 2023. A sustained downward trend emerged in 2024, reaching a multi-year low of 12.71 by June 30, 2025. Following this trough, the ratio entered a recovery phase, climbing steadily to 18.25 by September 30, 2026.

Share Price Correlation

The fluctuations in the P/E ratio are primarily driven by volatility in the share price rather than significant shifts in earnings. A marked decline in market valuation is evident from March 31, 2024, where the share price stood at 525.19, falling to a low of 302.45 by June 30, 2025. This price compression resulted in the contraction of the P/E ratio. The subsequent rebound in the ratio to 18.25 coincides with a share price recovery to 434.13 by the end of the analyzed period.

Earnings per Share (EPS) Stability

Earnings per share demonstrated relative resilience throughout the analyzed timeframe. EPS peaked at 28.85 in June 2024 before experiencing a gradual decline to a low of 22.88 in June 2026. Because the EPS remained within a tighter range (approximately 22.88 to 28.85) compared to the wide swings in share price, the P/E ratio served as a direct proxy for market sentiment and investor confidence rather than reflecting fundamental earnings instability.

Valuation Insight

The divergence between stable earnings and a volatile share price suggests that the valuation compression observed in 2024 and early 2025 was likely driven by external market factors or sector-specific headwinds. The recovery of the P/E ratio in late 2025 and 2026 indicates a restoration of the valuation multiple, returning the stock to levels consistent with the 2022-2023 period.

The Price to Operating Profit (P/OP) ratio exhibits significant volatility over the analyzed period, characterized by a prolonged phase of valuation compression followed by a sharp expansion in the final quarters.

Share Price Dynamics

The share price experienced substantial fluctuations, beginning at 529.84 in March 2022 and reaching a low of 302.45 in June 2025. A recovery phase is observed starting in the second half of 2025, with the price climbing to 434.13 by September 2026.

Operating Profitability Trends

Operating profit per share demonstrated steady growth from March 2022 (30.22) to a peak in June 2024 (34.99). Subsequently, a consistent downward trajectory occurred, with the figure dropping to 22.84 by September 2026, representing a notable contraction in operating performance.

P/OP Ratio Analysis

The P/OP ratio declined from 17.53 in March 2022 to a period low of 9.63 in June 2025. This compression indicates a period where the market valuation of the company's operating profits became increasingly conservative. However, the ratio expanded rapidly throughout 2026, ending at 19.01, the highest level in the observed series. This late-stage expansion is primarily driven by a recovering share price that outpaced the simultaneous decline in operating profit per share.

Overall, the divergence observed in 2026 suggests a shift in market sentiment, as the valuation multiple increased significantly despite weakening operating fundamentals.

The valuation analysis reveals a consistent divergence between the company's revenue growth and its market valuation multiple over the period from March 2022 to September 2026. While top-line efficiency per share demonstrates an uninterrupted upward trajectory, the price-to-sales ratio has experienced a significant long-term compression, indicating a decline in the multiple the market is willing to pay for each dollar of revenue.

Sales per Share Trend

A sustained and linear increase in sales per share is observed, rising from 592.04 US$ in March 2022 to 921.39 US$ by September 2026. This consistent growth indicates a strong and steady expansion of the company's revenue-generating capacity on a per-share basis throughout the entire analyzed timeframe.

Share Price Volatility

The share price exhibits significant volatility compared to the stability of sales growth. After maintaining a range between 457.33 US$ and 529.84 US$ from March 2022 through June 2024, a sharp decline occurred, reaching a trough of 302.45 US$ in June 2025. A partial recovery is noted in the final periods, with the price ascending to 434.13 US$ by September 2026.

Price-to-Sales (P/S) Ratio Dynamics

The P/S ratio reflects a general downward trend, starting at 0.89 in March 2022 and ending at 0.47 in September 2026. The most acute compression occurred between March 2024 (0.72) and June 2025 (0.36). This suggests that the share price declined at a rate that far outpaced the growth in sales, leading to a valuation low in mid-2025. The subsequent increase in the P/S ratio to 0.47 by late 2026 indicates a moderate recovery in market sentiment, although the valuation remains substantially lower than the 2022 levels.

The overall pattern suggests that while the fundamental ability to generate sales has improved significantly, the market valuation has undergone a structural re-rating. The contraction of the P/S ratio despite rising sales per share implies that external market pressures or changes in investor risk perception have offset the positive impact of the company's revenue growth.

The financial data reveals a divergent trend between the steady growth of intrinsic book value and the volatility of the market price, resulting in a general compression of the Price to Book Value (P/BV) multiple over the analyzed period.

Book Value Per Share (BVPS) Growth

A consistent upward trajectory in Book Value per Share is observed, rising from 149.22 US$ in March 2022 to 206.80 US$ by September 2026. This steady increase indicates a consistent growth in the company's net asset value on a per-share basis throughout the entire period.

Share Price Volatility

The share price exhibited significant fluctuations, characterized by a period of relative stability between 450 US$ and 530 US$ from March 2022 through March 2024. However, a sharp decline occurred starting in September 2024, with the price reaching a period low of 302.45 US$ in June 2025. A subsequent recovery phase is noted from mid-2025 onward, with the price climbing back to 434.13 US$ by September 2026.

P/BV Ratio Analysis

The P/BV ratio experienced a marked contraction, falling from a peak of 3.55 in March 2022 to a minimum of 1.56 in June 2025. This downward trend suggests a decrease in the market premium assigned to the company's book value. The ratio remained relatively stable around the 3.0 level through 2023 before the steep decline in 2024 and 2025. Following the trough in June 2025, the ratio began a gradual ascent, recovering to 2.10 by September 2026.

Valuation Synthesis

The compression of the P/BV ratio was driven primarily by the decline in share price rather than a lack of growth in book value. The fact that the P/BV ratio reached its lowest point while BVPS continued to rise suggests a period of significant market undervaluation or a shift in investor sentiment regarding the company's asset utilization and future earnings potential during 2024 and 2025.